Hallmark,Disease,LossDiff
HALLMARK_ADIPOGENESIS,Kidney Renal Papillary Cell Carcinoma,0.005859880171605991
HALLMARK_ADIPOGENESIS,Thyroid Carcinoma,0.0013212591240351836
HALLMARK_ADIPOGENESIS,Liver Hepatocellular Carcinoma,0.004993103329670468
HALLMARK_ADIPOGENESIS,Breast Invasive Carcinoma,0.004040632661000676
HALLMARK_ADIPOGENESIS,Prostate Adenocarcinoma,0.0008744979936303826
HALLMARK_ADIPOGENESIS,Bladder Urothelial Carcinoma,0.01980081465868483
HALLMARK_ADIPOGENESIS,Stomach Adenocarcinoma,0.009197340460009407
HALLMARK_ADIPOGENESIS,Lung Squamous Cell Carcinoma,0.011300418855053396
HALLMARK_ADIPOGENESIS,Ovarian Serous Cystadenocarcinoma,0.009392831656470247
HALLMARK_ADIPOGENESIS,Brain Lower Grade Glioma,0.004983253179160718
HALLMARK_ADIPOGENESIS,Skin Cutaneous Melanoma,0.01410074303230593
HALLMARK_ADIPOGENESIS,Lung Adenocarcinoma,0.011886656633043946
HALLMARK_ADIPOGENESIS,Kidney Renal Clear Cell Carcinoma,0.009698913085919136
HALLMARK_ADIPOGENESIS,Colon Adenocarcinoma,0.013690267164372289
HALLMARK_ADIPOGENESIS,Uterine Corpus Endometrial Carcinoma,0.006930836756450803
HALLMARK_ADIPOGENESIS,Head and Neck Squamous Cell Carcinoma,0.01707910273583404
HALLMARK_ADIPOGENESIS,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.010079471496018472
HALLMARK_ALLOGRAFT_REJECTION,Kidney Renal Papillary Cell Carcinoma,0.008596167581208531
HALLMARK_ALLOGRAFT_REJECTION,Thyroid Carcinoma,0.0026627362536435746
HALLMARK_ALLOGRAFT_REJECTION,Liver Hepatocellular Carcinoma,0.027086931514109035
HALLMARK_ALLOGRAFT_REJECTION,Breast Invasive Carcinoma,0.00899264359762857
HALLMARK_ALLOGRAFT_REJECTION,Prostate Adenocarcinoma,0.001978863744558816
HALLMARK_ALLOGRAFT_REJECTION,Bladder Urothelial Carcinoma,0.04789458371212333
HALLMARK_ALLOGRAFT_REJECTION,Stomach Adenocarcinoma,0.02738839324170219
HALLMARK_ALLOGRAFT_REJECTION,Lung Squamous Cell Carcinoma,0.042158347222731686
HALLMARK_ALLOGRAFT_REJECTION,Ovarian Serous Cystadenocarcinoma,0.03363168801597103
HALLMARK_ALLOGRAFT_REJECTION,Brain Lower Grade Glioma,0.0113608568119688
HALLMARK_ALLOGRAFT_REJECTION,Skin Cutaneous Melanoma,0.04775036394097829
HALLMARK_ALLOGRAFT_REJECTION,Lung Adenocarcinoma,0.03195316481886572
HALLMARK_ALLOGRAFT_REJECTION,Kidney Renal Clear Cell Carcinoma,0.014432853253988121
HALLMARK_ALLOGRAFT_REJECTION,Colon Adenocarcinoma,0.03930306812393228
HALLMARK_ALLOGRAFT_REJECTION,Uterine Corpus Endometrial Carcinoma,0.014562789327910625
HALLMARK_ALLOGRAFT_REJECTION,Head and Neck Squamous Cell Carcinoma,0.047052492420685446
HALLMARK_ALLOGRAFT_REJECTION,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.03506911235776816
HALLMARK_ANDROGEN_RESPONSE,Kidney Renal Papillary Cell Carcinoma,0.0032664801186566617
HALLMARK_ANDROGEN_RESPONSE,Thyroid Carcinoma,-0.0008983232842927687
HALLMARK_ANDROGEN_RESPONSE,Liver Hepatocellular Carcinoma,0.0038313128238805726
HALLMARK_ANDROGEN_RESPONSE,Breast Invasive Carcinoma,0.0013982660392553136
HALLMARK_ANDROGEN_RESPONSE,Prostate Adenocarcinoma,0.00034918461422451245
HALLMARK_ANDROGEN_RESPONSE,Bladder Urothelial Carcinoma,0.011634739083963041
HALLMARK_ANDROGEN_RESPONSE,Stomach Adenocarcinoma,0.009077992656176582
HALLMARK_ANDROGEN_RESPONSE,Lung Squamous Cell Carcinoma,0.008946332410989988
HALLMARK_ANDROGEN_RESPONSE,Ovarian Serous Cystadenocarcinoma,0.00514661845757598
HALLMARK_ANDROGEN_RESPONSE,Brain Lower Grade Glioma,0.003472296840630984
HALLMARK_ANDROGEN_RESPONSE,Skin Cutaneous Melanoma,0.006849619281665919
HALLMARK_ANDROGEN_RESPONSE,Lung Adenocarcinoma,0.00784616791167555
HALLMARK_ANDROGEN_RESPONSE,Kidney Renal Clear Cell Carcinoma,1.4882563398432858e-05
HALLMARK_ANDROGEN_RESPONSE,Colon Adenocarcinoma,0.010739046818635934
HALLMARK_ANDROGEN_RESPONSE,Uterine Corpus Endometrial Carcinoma,0.0027187394540541033
HALLMARK_ANDROGEN_RESPONSE,Head and Neck Squamous Cell Carcinoma,0.007734529409311774
HALLMARK_ANDROGEN_RESPONSE,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.008184428919445385
HALLMARK_ANGIOGENESIS,Kidney Renal Papillary Cell Carcinoma,0.0005616192080510174
HALLMARK_ANGIOGENESIS,Thyroid Carcinoma,0.001134221848439084
HALLMARK_ANGIOGENESIS,Liver Hepatocellular Carcinoma,0.0023495501835053335
HALLMARK_ANGIOGENESIS,Breast Invasive Carcinoma,0.0010155253534270214
HALLMARK_ANGIOGENESIS,Prostate Adenocarcinoma,-1.6809982003369752e-05
HALLMARK_ANGIOGENESIS,Bladder Urothelial Carcinoma,0.003762789379647402
HALLMARK_ANGIOGENESIS,Stomach Adenocarcinoma,0.003474194122536289
HALLMARK_ANGIOGENESIS,Lung Squamous Cell Carcinoma,0.006387266129651436
HALLMARK_ANGIOGENESIS,Ovarian Serous Cystadenocarcinoma,0.003740170969891943
HALLMARK_ANGIOGENESIS,Brain Lower Grade Glioma,0.0019158052661746416
HALLMARK_ANGIOGENESIS,Skin Cutaneous Melanoma,0.0035017223396775375
HALLMARK_ANGIOGENESIS,Lung Adenocarcinoma,0.0016907413971131713
HALLMARK_ANGIOGENESIS,Kidney Renal Clear Cell Carcinoma,0.0029885888271606875
HALLMARK_ANGIOGENESIS,Colon Adenocarcinoma,0.00514891143626593
HALLMARK_ANGIOGENESIS,Uterine Corpus Endometrial Carcinoma,0.0020182293220634973
HALLMARK_ANGIOGENESIS,Head and Neck Squamous Cell Carcinoma,0.00183622747810962
HALLMARK_ANGIOGENESIS,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.0033027658408338436
HALLMARK_APICAL_JUNCTION,Kidney Renal Papillary Cell Carcinoma,0.004791550507092668
HALLMARK_APICAL_JUNCTION,Thyroid Carcinoma,0.0008761862631548496
HALLMARK_APICAL_JUNCTION,Liver Hepatocellular Carcinoma,0.004400141467021157
HALLMARK_APICAL_JUNCTION,Breast Invasive Carcinoma,0.0024203511794398335
HALLMARK_APICAL_JUNCTION,Prostate Adenocarcinoma,0.0004213036602882086
HALLMARK_APICAL_JUNCTION,Bladder Urothelial Carcinoma,0.017378045072607283
HALLMARK_APICAL_JUNCTION,Stomach Adenocarcinoma,0.010143865202882296
HALLMARK_APICAL_JUNCTION,Lung Squamous Cell Carcinoma,0.010080384976877688
HALLMARK_APICAL_JUNCTION,Ovarian Serous Cystadenocarcinoma,0.006121558470512522
HALLMARK_APICAL_JUNCTION,Brain Lower Grade Glioma,0.0037788064221050744
HALLMARK_APICAL_JUNCTION,Skin Cutaneous Melanoma,0.014869336707550307
HALLMARK_APICAL_JUNCTION,Lung Adenocarcinoma,0.011020909414222268
HALLMARK_APICAL_JUNCTION,Kidney Renal Clear Cell Carcinoma,0.0016487781073038388
HALLMARK_APICAL_JUNCTION,Colon Adenocarcinoma,0.010530560426289415
HALLMARK_APICAL_JUNCTION,Uterine Corpus Endometrial Carcinoma,0.005572715495951458
HALLMARK_APICAL_JUNCTION,Head and Neck Squamous Cell Carcinoma,0.014414478467805757
HALLMARK_APICAL_JUNCTION,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.010427939688617544
HALLMARK_APICAL_SURFACE,Kidney Renal Papillary Cell Carcinoma,7.784048230480289e-06
HALLMARK_APICAL_SURFACE,Thyroid Carcinoma,0.0002269141884012671
HALLMARK_APICAL_SURFACE,Liver Hepatocellular Carcinoma,0.001056535785229218
HALLMARK_APICAL_SURFACE,Breast Invasive Carcinoma,0.0010423417540359136
HALLMARK_APICAL_SURFACE,Prostate Adenocarcinoma,0.0004909981427653166
HALLMARK_APICAL_SURFACE,Bladder Urothelial Carcinoma,0.005558038872960658
HALLMARK_APICAL_SURFACE,Stomach Adenocarcinoma,0.004032708855915901
HALLMARK_APICAL_SURFACE,Lung Squamous Cell Carcinoma,0.0038170778747204535
HALLMARK_APICAL_SURFACE,Ovarian Serous Cystadenocarcinoma,0.0020547346535013666
HALLMARK_APICAL_SURFACE,Brain Lower Grade Glioma,0.001686623467583448
HALLMARK_APICAL_SURFACE,Skin Cutaneous Melanoma,0.00464362788400694
HALLMARK_APICAL_SURFACE,Lung Adenocarcinoma,0.0033115454145608457
HALLMARK_APICAL_SURFACE,Kidney Renal Clear Cell Carcinoma,0.00015997221263555072
HALLMARK_APICAL_SURFACE,Colon Adenocarcinoma,0.001699853287293357
HALLMARK_APICAL_SURFACE,Uterine Corpus Endometrial Carcinoma,0.0018263522451453962
HALLMARK_APICAL_SURFACE,Head and Neck Squamous Cell Carcinoma,0.002705408020067934
HALLMARK_APICAL_SURFACE,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.003978882743553689
HALLMARK_APOPTOSIS,Kidney Renal Papillary Cell Carcinoma,0.008486052649190529
HALLMARK_APOPTOSIS,Thyroid Carcinoma,0.0005055775273252614
HALLMARK_APOPTOSIS,Liver Hepatocellular Carcinoma,0.0037250891316281676
HALLMARK_APOPTOSIS,Breast Invasive Carcinoma,0.006425383173307764
HALLMARK_APOPTOSIS,Prostate Adenocarcinoma,0.0015794598497450361
HALLMARK_APOPTOSIS,Bladder Urothelial Carcinoma,0.037100189986635154
HALLMARK_APOPTOSIS,Stomach Adenocarcinoma,0.025638247343581767
HALLMARK_APOPTOSIS,Lung Squamous Cell Carcinoma,0.020316255981663246
HALLMARK_APOPTOSIS,Ovarian Serous Cystadenocarcinoma,0.01637880887083749
HALLMARK_APOPTOSIS,Brain Lower Grade Glioma,0.00769070236125019
HALLMARK_APOPTOSIS,Skin Cutaneous Melanoma,0.020258183073071277
HALLMARK_APOPTOSIS,Lung Adenocarcinoma,0.01619448959504156
HALLMARK_APOPTOSIS,Kidney Renal Clear Cell Carcinoma,0.0050193173094437715
HALLMARK_APOPTOSIS,Colon Adenocarcinoma,0.023243409245707912
HALLMARK_APOPTOSIS,Uterine Corpus Endometrial Carcinoma,0.01095722694619466
HALLMARK_APOPTOSIS,Head and Neck Squamous Cell Carcinoma,0.021100848383709868
HALLMARK_APOPTOSIS,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.019254781048406257
HALLMARK_BILE_ACID_METABOLISM,Kidney Renal Papillary Cell Carcinoma,0.004263815997352061
HALLMARK_BILE_ACID_METABOLISM,Thyroid Carcinoma,0.0008148869330232775
HALLMARK_BILE_ACID_METABOLISM,Liver Hepatocellular Carcinoma,0.008164564334691671
HALLMARK_BILE_ACID_METABOLISM,Breast Invasive Carcinoma,0.0028515648934903048
HALLMARK_BILE_ACID_METABOLISM,Prostate Adenocarcinoma,0.0010770312809420973
HALLMARK_BILE_ACID_METABOLISM,Bladder Urothelial Carcinoma,0.01267078474376585
HALLMARK_BILE_ACID_METABOLISM,Stomach Adenocarcinoma,0.008322235802705469
HALLMARK_BILE_ACID_METABOLISM,Lung Squamous Cell Carcinoma,0.010898017599345033
HALLMARK_BILE_ACID_METABOLISM,Ovarian Serous Cystadenocarcinoma,0.007649659059534053
HALLMARK_BILE_ACID_METABOLISM,Brain Lower Grade Glioma,0.005191627214189998
HALLMARK_BILE_ACID_METABOLISM,Skin Cutaneous Melanoma,0.011208241140783625
HALLMARK_BILE_ACID_METABOLISM,Lung Adenocarcinoma,0.009640705873763977
HALLMARK_BILE_ACID_METABOLISM,Kidney Renal Clear Cell Carcinoma,0.0012550551215043337
HALLMARK_BILE_ACID_METABOLISM,Colon Adenocarcinoma,0.008602257935099783
HALLMARK_BILE_ACID_METABOLISM,Uterine Corpus Endometrial Carcinoma,0.004094615241604022
HALLMARK_BILE_ACID_METABOLISM,Head and Neck Squamous Cell Carcinoma,0.012587128889742205
HALLMARK_BILE_ACID_METABOLISM,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.009536850452423095
HALLMARK_CHOLESTEROL_HOMEOSTASIS,Kidney Renal Papillary Cell Carcinoma,0.0016124264606314164
HALLMARK_CHOLESTEROL_HOMEOSTASIS,Thyroid Carcinoma,0.0004849456589330347
HALLMARK_CHOLESTEROL_HOMEOSTASIS,Liver Hepatocellular Carcinoma,0.0024430781398964373
HALLMARK_CHOLESTEROL_HOMEOSTASIS,Breast Invasive Carcinoma,0.003272743990415411
HALLMARK_CHOLESTEROL_HOMEOSTASIS,Prostate Adenocarcinoma,0.0007327451100929176
HALLMARK_CHOLESTEROL_HOMEOSTASIS,Bladder Urothelial Carcinoma,0.01344473269190779
HALLMARK_CHOLESTEROL_HOMEOSTASIS,Stomach Adenocarcinoma,0.007285988295145129
HALLMARK_CHOLESTEROL_HOMEOSTASIS,Lung Squamous Cell Carcinoma,0.01384590082101247
HALLMARK_CHOLESTEROL_HOMEOSTASIS,Ovarian Serous Cystadenocarcinoma,0.008732353173678176
HALLMARK_CHOLESTEROL_HOMEOSTASIS,Brain Lower Grade Glioma,0.00266517464735917
HALLMARK_CHOLESTEROL_HOMEOSTASIS,Skin Cutaneous Melanoma,0.008789394630765801
HALLMARK_CHOLESTEROL_HOMEOSTASIS,Lung Adenocarcinoma,0.0073660024903428045
HALLMARK_CHOLESTEROL_HOMEOSTASIS,Kidney Renal Clear Cell Carcinoma,0.0033503993314045856
HALLMARK_CHOLESTEROL_HOMEOSTASIS,Colon Adenocarcinoma,0.010183539154338195
HALLMARK_CHOLESTEROL_HOMEOSTASIS,Uterine Corpus Endometrial Carcinoma,0.0041268897340042575
HALLMARK_CHOLESTEROL_HOMEOSTASIS,Head and Neck Squamous Cell Carcinoma,0.013329680407712863
HALLMARK_CHOLESTEROL_HOMEOSTASIS,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.00851586610078813
HALLMARK_COAGULATION,Kidney Renal Papillary Cell Carcinoma,0.005830561354279851
HALLMARK_COAGULATION,Thyroid Carcinoma,0.0006626263260841311
HALLMARK_COAGULATION,Liver Hepatocellular Carcinoma,-0.0017708722558848367
HALLMARK_COAGULATION,Breast Invasive Carcinoma,0.0046019872541638255
HALLMARK_COAGULATION,Prostate Adenocarcinoma,0.0007172599560810151
HALLMARK_COAGULATION,Bladder Urothelial Carcinoma,0.01859128356482913
HALLMARK_COAGULATION,Stomach Adenocarcinoma,0.015452630301741599
HALLMARK_COAGULATION,Lung Squamous Cell Carcinoma,0.011942906672562592
HALLMARK_COAGULATION,Ovarian Serous Cystadenocarcinoma,0.009359494107279608
HALLMARK_COAGULATION,Brain Lower Grade Glioma,0.005229314020260056
HALLMARK_COAGULATION,Skin Cutaneous Melanoma,0.012399197213212277
HALLMARK_COAGULATION,Lung Adenocarcinoma,0.011658541217520546
HALLMARK_COAGULATION,Kidney Renal Clear Cell Carcinoma,0.010379052663651777
HALLMARK_COAGULATION,Colon Adenocarcinoma,0.01428225314039051
HALLMARK_COAGULATION,Uterine Corpus Endometrial Carcinoma,0.005353592036617266
HALLMARK_COAGULATION,Head and Neck Squamous Cell Carcinoma,0.010887528736579222
HALLMARK_COAGULATION,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.008339711319316523
HALLMARK_COMPLEMENT,Kidney Renal Papillary Cell Carcinoma,0.006583336205681645
HALLMARK_COMPLEMENT,Thyroid Carcinoma,0.0005392469719729634
HALLMARK_COMPLEMENT,Liver Hepatocellular Carcinoma,0.003956317587627522
HALLMARK_COMPLEMENT,Breast Invasive Carcinoma,0.007161890765577178
HALLMARK_COMPLEMENT,Prostate Adenocarcinoma,0.0019449656583684308
HALLMARK_COMPLEMENT,Bladder Urothelial Carcinoma,0.021078543731407974
HALLMARK_COMPLEMENT,Stomach Adenocarcinoma,0.014456901251534237
HALLMARK_COMPLEMENT,Lung Squamous Cell Carcinoma,0.018557290000482764
HALLMARK_COMPLEMENT,Ovarian Serous Cystadenocarcinoma,0.011866449040559978
HALLMARK_COMPLEMENT,Brain Lower Grade Glioma,0.0077574520799186366
HALLMARK_COMPLEMENT,Skin Cutaneous Melanoma,0.02082894797456647
HALLMARK_COMPLEMENT,Lung Adenocarcinoma,0.014166957438831129
HALLMARK_COMPLEMENT,Kidney Renal Clear Cell Carcinoma,0.004715314424381789
HALLMARK_COMPLEMENT,Colon Adenocarcinoma,0.013234409645050248
HALLMARK_COMPLEMENT,Uterine Corpus Endometrial Carcinoma,0.00814242380767009
HALLMARK_COMPLEMENT,Head and Neck Squamous Cell Carcinoma,0.015647776417320736
HALLMARK_COMPLEMENT,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.01742309990254316
HALLMARK_DNA_REPAIR,Kidney Renal Papillary Cell Carcinoma,0.0005518001874741995
HALLMARK_DNA_REPAIR,Thyroid Carcinoma,0.000988369054076344
HALLMARK_DNA_REPAIR,Liver Hepatocellular Carcinoma,0.006327097653518132
HALLMARK_DNA_REPAIR,Breast Invasive Carcinoma,0.0034517742797488095
HALLMARK_DNA_REPAIR,Prostate Adenocarcinoma,0.0010326603161618926
HALLMARK_DNA_REPAIR,Bladder Urothelial Carcinoma,0.013817416210238765
HALLMARK_DNA_REPAIR,Stomach Adenocarcinoma,0.007808284031657453
HALLMARK_DNA_REPAIR,Lung Squamous Cell Carcinoma,0.013158233638924632
HALLMARK_DNA_REPAIR,Ovarian Serous Cystadenocarcinoma,0.005641443361690412
HALLMARK_DNA_REPAIR,Brain Lower Grade Glioma,0.0036110876727635686
HALLMARK_DNA_REPAIR,Skin Cutaneous Melanoma,0.013688303791325174
HALLMARK_DNA_REPAIR,Lung Adenocarcinoma,0.009377809089084676
HALLMARK_DNA_REPAIR,Kidney Renal Clear Cell Carcinoma,0.002296732460650097
HALLMARK_DNA_REPAIR,Colon Adenocarcinoma,0.007199034049957503
HALLMARK_DNA_REPAIR,Uterine Corpus Endometrial Carcinoma,0.007027814931149334
HALLMARK_DNA_REPAIR,Head and Neck Squamous Cell Carcinoma,0.009837303321978763
HALLMARK_DNA_REPAIR,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.006472654600035055
HALLMARK_E2F_TARGETS,Kidney Renal Papillary Cell Carcinoma,0.0069469770602898495
HALLMARK_E2F_TARGETS,Thyroid Carcinoma,0.002040670812129975
HALLMARK_E2F_TARGETS,Liver Hepatocellular Carcinoma,0.015091202229965683
HALLMARK_E2F_TARGETS,Breast Invasive Carcinoma,0.004866231899965712
HALLMARK_E2F_TARGETS,Prostate Adenocarcinoma,0.0010898708515988836
HALLMARK_E2F_TARGETS,Bladder Urothelial Carcinoma,0.017996658384620324
HALLMARK_E2F_TARGETS,Stomach Adenocarcinoma,0.010203993450808446
HALLMARK_E2F_TARGETS,Lung Squamous Cell Carcinoma,0.009503445141116429
HALLMARK_E2F_TARGETS,Ovarian Serous Cystadenocarcinoma,0.00621754017753986
HALLMARK_E2F_TARGETS,Brain Lower Grade Glioma,0.00810756454811733
HALLMARK_E2F_TARGETS,Skin Cutaneous Melanoma,0.016382483336398246
HALLMARK_E2F_TARGETS,Lung Adenocarcinoma,0.013326572174403795
HALLMARK_E2F_TARGETS,Kidney Renal Clear Cell Carcinoma,0.004895194591237939
HALLMARK_E2F_TARGETS,Colon Adenocarcinoma,0.011168057498923916
HALLMARK_E2F_TARGETS,Uterine Corpus Endometrial Carcinoma,0.0071436650045639425
HALLMARK_E2F_TARGETS,Head and Neck Squamous Cell Carcinoma,0.018171180202271108
HALLMARK_E2F_TARGETS,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.011707124086943535
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,Kidney Renal Papillary Cell Carcinoma,0.0071985217168186785
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,Thyroid Carcinoma,0.0010500557551329753
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,Liver Hepatocellular Carcinoma,0.009708797804255242
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,Breast Invasive Carcinoma,0.004729427979733414
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,Prostate Adenocarcinoma,0.0010859866905194072
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,Bladder Urothelial Carcinoma,0.023708778458329516
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,Stomach Adenocarcinoma,0.014053581067679021
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,Lung Squamous Cell Carcinoma,0.013252805459573191
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,Ovarian Serous Cystadenocarcinoma,0.011289249249358679
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,Brain Lower Grade Glioma,0.006648489026648996
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,Skin Cutaneous Melanoma,0.01692440827407915
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,Lung Adenocarcinoma,0.012246644958106335
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,Kidney Renal Clear Cell Carcinoma,0.01075255413468067
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,Colon Adenocarcinoma,0.016019242493603945
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,Uterine Corpus Endometrial Carcinoma,0.006002244120853662
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,Head and Neck Squamous Cell Carcinoma,0.015615706516401418
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.016972263468937432
HALLMARK_ESTROGEN_RESPONSE_EARLY,Kidney Renal Papillary Cell Carcinoma,0.004430347761695807
HALLMARK_ESTROGEN_RESPONSE_EARLY,Thyroid Carcinoma,0.0006977619518610545
HALLMARK_ESTROGEN_RESPONSE_EARLY,Liver Hepatocellular Carcinoma,0.011055390853420333
HALLMARK_ESTROGEN_RESPONSE_EARLY,Breast Invasive Carcinoma,0.007816914780202671
HALLMARK_ESTROGEN_RESPONSE_EARLY,Prostate Adenocarcinoma,0.0008480307148626996
HALLMARK_ESTROGEN_RESPONSE_EARLY,Bladder Urothelial Carcinoma,0.026249781081253486
HALLMARK_ESTROGEN_RESPONSE_EARLY,Stomach Adenocarcinoma,0.018973297837797977
HALLMARK_ESTROGEN_RESPONSE_EARLY,Lung Squamous Cell Carcinoma,0.02734580804681459
HALLMARK_ESTROGEN_RESPONSE_EARLY,Ovarian Serous Cystadenocarcinoma,0.01569383969235776
HALLMARK_ESTROGEN_RESPONSE_EARLY,Brain Lower Grade Glioma,0.0065641436357389725
HALLMARK_ESTROGEN_RESPONSE_EARLY,Skin Cutaneous Melanoma,0.01903821847253324
HALLMARK_ESTROGEN_RESPONSE_EARLY,Lung Adenocarcinoma,0.024765740925358538
HALLMARK_ESTROGEN_RESPONSE_EARLY,Kidney Renal Clear Cell Carcinoma,0.006739670554032673
HALLMARK_ESTROGEN_RESPONSE_EARLY,Colon Adenocarcinoma,0.01949244856734738
HALLMARK_ESTROGEN_RESPONSE_EARLY,Uterine Corpus Endometrial Carcinoma,0.012150444239450392
HALLMARK_ESTROGEN_RESPONSE_EARLY,Head and Neck Squamous Cell Carcinoma,0.025246233928022034
HALLMARK_ESTROGEN_RESPONSE_EARLY,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.020508275858380574
HALLMARK_ESTROGEN_RESPONSE_LATE,Kidney Renal Papillary Cell Carcinoma,0.006189283787008293
HALLMARK_ESTROGEN_RESPONSE_LATE,Thyroid Carcinoma,0.0009349934333427367
HALLMARK_ESTROGEN_RESPONSE_LATE,Liver Hepatocellular Carcinoma,0.011086204368464747
HALLMARK_ESTROGEN_RESPONSE_LATE,Breast Invasive Carcinoma,0.00944615649710342
HALLMARK_ESTROGEN_RESPONSE_LATE,Prostate Adenocarcinoma,0.0012753021356247652
HALLMARK_ESTROGEN_RESPONSE_LATE,Bladder Urothelial Carcinoma,0.02963088887090396
HALLMARK_ESTROGEN_RESPONSE_LATE,Stomach Adenocarcinoma,0.017393752434302447
HALLMARK_ESTROGEN_RESPONSE_LATE,Lung Squamous Cell Carcinoma,0.02421777887960084
HALLMARK_ESTROGEN_RESPONSE_LATE,Ovarian Serous Cystadenocarcinoma,0.020506056637313242
HALLMARK_ESTROGEN_RESPONSE_LATE,Brain Lower Grade Glioma,0.006680896365541156
HALLMARK_ESTROGEN_RESPONSE_LATE,Skin Cutaneous Melanoma,0.024814670206327483
HALLMARK_ESTROGEN_RESPONSE_LATE,Lung Adenocarcinoma,0.024608461515013245
HALLMARK_ESTROGEN_RESPONSE_LATE,Kidney Renal Clear Cell Carcinoma,0.010155750258037655
HALLMARK_ESTROGEN_RESPONSE_LATE,Colon Adenocarcinoma,0.02362163957943486
HALLMARK_ESTROGEN_RESPONSE_LATE,Uterine Corpus Endometrial Carcinoma,0.008708192004474636
HALLMARK_ESTROGEN_RESPONSE_LATE,Head and Neck Squamous Cell Carcinoma,0.028516179716526525
HALLMARK_ESTROGEN_RESPONSE_LATE,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.02344911480491812
HALLMARK_FATTY_ACID_METABOLISM,Kidney Renal Papillary Cell Carcinoma,0.002351183799861939
HALLMARK_FATTY_ACID_METABOLISM,Thyroid Carcinoma,-0.00020350869745016238
HALLMARK_FATTY_ACID_METABOLISM,Liver Hepatocellular Carcinoma,0.0013608461943610429
HALLMARK_FATTY_ACID_METABOLISM,Breast Invasive Carcinoma,0.0028428120174316452
HALLMARK_FATTY_ACID_METABOLISM,Prostate Adenocarcinoma,0.0008736443526462703
HALLMARK_FATTY_ACID_METABOLISM,Bladder Urothelial Carcinoma,0.01652519396983978
HALLMARK_FATTY_ACID_METABOLISM,Stomach Adenocarcinoma,0.00877771108331491
HALLMARK_FATTY_ACID_METABOLISM,Lung Squamous Cell Carcinoma,0.010544486783503237
HALLMARK_FATTY_ACID_METABOLISM,Ovarian Serous Cystadenocarcinoma,0.007570398920211075
HALLMARK_FATTY_ACID_METABOLISM,Brain Lower Grade Glioma,0.0030390960193388385
HALLMARK_FATTY_ACID_METABOLISM,Skin Cutaneous Melanoma,0.010155631931641863
HALLMARK_FATTY_ACID_METABOLISM,Lung Adenocarcinoma,0.007361573796383092
HALLMARK_FATTY_ACID_METABOLISM,Kidney Renal Clear Cell Carcinoma,0.002543747637134319
HALLMARK_FATTY_ACID_METABOLISM,Colon Adenocarcinoma,0.010140709040755019
HALLMARK_FATTY_ACID_METABOLISM,Uterine Corpus Endometrial Carcinoma,0.0042552992692896805
HALLMARK_FATTY_ACID_METABOLISM,Head and Neck Squamous Cell Carcinoma,0.008452369250016755
HALLMARK_FATTY_ACID_METABOLISM,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.00758540070869706
HALLMARK_G2M_CHECKPOINT,Kidney Renal Papillary Cell Carcinoma,0.009678293184199627
HALLMARK_G2M_CHECKPOINT,Thyroid Carcinoma,0.0016725186935879943
HALLMARK_G2M_CHECKPOINT,Liver Hepatocellular Carcinoma,0.01398377014775506
HALLMARK_G2M_CHECKPOINT,Breast Invasive Carcinoma,0.005980653428057347
HALLMARK_G2M_CHECKPOINT,Prostate Adenocarcinoma,0.001295715246522606
HALLMARK_G2M_CHECKPOINT,Bladder Urothelial Carcinoma,0.022013010202892223
HALLMARK_G2M_CHECKPOINT,Stomach Adenocarcinoma,0.010586647265712835
HALLMARK_G2M_CHECKPOINT,Lung Squamous Cell Carcinoma,0.01405367329818874
HALLMARK_G2M_CHECKPOINT,Ovarian Serous Cystadenocarcinoma,0.011081076528302503
HALLMARK_G2M_CHECKPOINT,Brain Lower Grade Glioma,0.011045490292008497
HALLMARK_G2M_CHECKPOINT,Skin Cutaneous Melanoma,0.010254112601526578
HALLMARK_G2M_CHECKPOINT,Lung Adenocarcinoma,0.013526139867562981
HALLMARK_G2M_CHECKPOINT,Kidney Renal Clear Cell Carcinoma,0.013782074712216841
HALLMARK_G2M_CHECKPOINT,Colon Adenocarcinoma,0.0116756692179868
HALLMARK_G2M_CHECKPOINT,Uterine Corpus Endometrial Carcinoma,0.006463397893515471
HALLMARK_G2M_CHECKPOINT,Head and Neck Squamous Cell Carcinoma,0.02125980826803874
HALLMARK_G2M_CHECKPOINT,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.015713328028267082
HALLMARK_GLYCOLYSIS,Kidney Renal Papillary Cell Carcinoma,0.004734258838073807
HALLMARK_GLYCOLYSIS,Thyroid Carcinoma,0.000759054026143112
HALLMARK_GLYCOLYSIS,Liver Hepatocellular Carcinoma,0.006218887264948491
HALLMARK_GLYCOLYSIS,Breast Invasive Carcinoma,0.0047054380315233015
HALLMARK_GLYCOLYSIS,Prostate Adenocarcinoma,0.001198464102249164
HALLMARK_GLYCOLYSIS,Bladder Urothelial Carcinoma,0.01809566112641999
HALLMARK_GLYCOLYSIS,Stomach Adenocarcinoma,0.00901959142110904
HALLMARK_GLYCOLYSIS,Lung Squamous Cell Carcinoma,0.011542173985913284
HALLMARK_GLYCOLYSIS,Ovarian Serous Cystadenocarcinoma,0.0046940171635565745
HALLMARK_GLYCOLYSIS,Brain Lower Grade Glioma,0.005879102870289176
HALLMARK_GLYCOLYSIS,Skin Cutaneous Melanoma,0.010615842189658853
HALLMARK_GLYCOLYSIS,Lung Adenocarcinoma,0.009925615230337559
HALLMARK_GLYCOLYSIS,Kidney Renal Clear Cell Carcinoma,0.0056363274042422916
HALLMARK_GLYCOLYSIS,Colon Adenocarcinoma,0.010908801260600514
HALLMARK_GLYCOLYSIS,Uterine Corpus Endometrial Carcinoma,0.005988724657855743
HALLMARK_GLYCOLYSIS,Head and Neck Squamous Cell Carcinoma,0.015284704617437339
HALLMARK_GLYCOLYSIS,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.014384525892409409
HALLMARK_HEDGEHOG_SIGNALING,Kidney Renal Papillary Cell Carcinoma,-3.3361497540129736e-06
HALLMARK_HEDGEHOG_SIGNALING,Thyroid Carcinoma,0.0006043122742663689
HALLMARK_HEDGEHOG_SIGNALING,Liver Hepatocellular Carcinoma,0.0010482281209699296
HALLMARK_HEDGEHOG_SIGNALING,Breast Invasive Carcinoma,0.0015874537418870405
HALLMARK_HEDGEHOG_SIGNALING,Prostate Adenocarcinoma,0.00025861755616535324
HALLMARK_HEDGEHOG_SIGNALING,Bladder Urothelial Carcinoma,0.00630934987701467
HALLMARK_HEDGEHOG_SIGNALING,Stomach Adenocarcinoma,0.003517531406499308
HALLMARK_HEDGEHOG_SIGNALING,Lung Squamous Cell Carcinoma,0.004257668869055831
HALLMARK_HEDGEHOG_SIGNALING,Ovarian Serous Cystadenocarcinoma,0.002556084379034895
HALLMARK_HEDGEHOG_SIGNALING,Brain Lower Grade Glioma,0.002209288444484958
HALLMARK_HEDGEHOG_SIGNALING,Skin Cutaneous Melanoma,0.00413877109253844
HALLMARK_HEDGEHOG_SIGNALING,Lung Adenocarcinoma,0.0017228908714309044
HALLMARK_HEDGEHOG_SIGNALING,Kidney Renal Clear Cell Carcinoma,0.005248451874806326
HALLMARK_HEDGEHOG_SIGNALING,Colon Adenocarcinoma,0.007306563390736593
HALLMARK_HEDGEHOG_SIGNALING,Uterine Corpus Endometrial Carcinoma,0.0004435772004116323
HALLMARK_HEDGEHOG_SIGNALING,Head and Neck Squamous Cell Carcinoma,0.0040142186250783475
HALLMARK_HEDGEHOG_SIGNALING,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.0038105623017657825
HALLMARK_HEME_METABOLISM,Kidney Renal Papillary Cell Carcinoma,0.00379919559100097
HALLMARK_HEME_METABOLISM,Thyroid Carcinoma,0.001342312187295065
HALLMARK_HEME_METABOLISM,Liver Hepatocellular Carcinoma,0.0022547963981362274
HALLMARK_HEME_METABOLISM,Breast Invasive Carcinoma,0.0027187782755716374
HALLMARK_HEME_METABOLISM,Prostate Adenocarcinoma,0.0009498620488492589
HALLMARK_HEME_METABOLISM,Bladder Urothelial Carcinoma,0.014997959127501848
HALLMARK_HEME_METABOLISM,Stomach Adenocarcinoma,0.004908799063597424
HALLMARK_HEME_METABOLISM,Lung Squamous Cell Carcinoma,0.010614973808046347
HALLMARK_HEME_METABOLISM,Ovarian Serous Cystadenocarcinoma,0.005880634023182419
HALLMARK_HEME_METABOLISM,Brain Lower Grade Glioma,0.0015472220698791173
HALLMARK_HEME_METABOLISM,Skin Cutaneous Melanoma,0.010585282603599876
HALLMARK_HEME_METABOLISM,Lung Adenocarcinoma,0.008503527849472258
HALLMARK_HEME_METABOLISM,Kidney Renal Clear Cell Carcinoma,0.005739710554480559
HALLMARK_HEME_METABOLISM,Colon Adenocarcinoma,0.008986597037235611
HALLMARK_HEME_METABOLISM,Uterine Corpus Endometrial Carcinoma,0.007340254278605124
HALLMARK_HEME_METABOLISM,Head and Neck Squamous Cell Carcinoma,0.011561333407000208
HALLMARK_HEME_METABOLISM,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.007728048373352397
HALLMARK_HYPOXIA,Kidney Renal Papillary Cell Carcinoma,0.003648288979293479
HALLMARK_HYPOXIA,Thyroid Carcinoma,-0.0006991159424863128
HALLMARK_HYPOXIA,Liver Hepatocellular Carcinoma,0.006701045019974439
HALLMARK_HYPOXIA,Breast Invasive Carcinoma,0.003960316949611969
HALLMARK_HYPOXIA,Prostate Adenocarcinoma,0.0012846320651247684
HALLMARK_HYPOXIA,Bladder Urothelial Carcinoma,0.02162530321228904
HALLMARK_HYPOXIA,Stomach Adenocarcinoma,0.014842651855001453
HALLMARK_HYPOXIA,Lung Squamous Cell Carcinoma,0.020096000212332755
HALLMARK_HYPOXIA,Ovarian Serous Cystadenocarcinoma,0.009681248317310476
HALLMARK_HYPOXIA,Brain Lower Grade Glioma,0.002558854652089515
HALLMARK_HYPOXIA,Skin Cutaneous Melanoma,0.017014491304729096
HALLMARK_HYPOXIA,Lung Adenocarcinoma,0.013156388993681179
HALLMARK_HYPOXIA,Kidney Renal Clear Cell Carcinoma,0.0052758153556631045
HALLMARK_HYPOXIA,Colon Adenocarcinoma,0.012437929023667704
HALLMARK_HYPOXIA,Uterine Corpus Endometrial Carcinoma,0.00841755215713586
HALLMARK_HYPOXIA,Head and Neck Squamous Cell Carcinoma,0.017252162174524976
HALLMARK_HYPOXIA,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.017524279152805154
HALLMARK_IL2_STAT5_SIGNALING,Kidney Renal Papillary Cell Carcinoma,0.004841114615676501
HALLMARK_IL2_STAT5_SIGNALING,Thyroid Carcinoma,0.0020815580913966314
HALLMARK_IL2_STAT5_SIGNALING,Liver Hepatocellular Carcinoma,0.009390492596919176
HALLMARK_IL2_STAT5_SIGNALING,Breast Invasive Carcinoma,0.004578031563510965
HALLMARK_IL2_STAT5_SIGNALING,Prostate Adenocarcinoma,0.0005779301037737092
HALLMARK_IL2_STAT5_SIGNALING,Bladder Urothelial Carcinoma,0.019764136085913632
HALLMARK_IL2_STAT5_SIGNALING,Stomach Adenocarcinoma,0.020679837847789873
HALLMARK_IL2_STAT5_SIGNALING,Lung Squamous Cell Carcinoma,0.02178287991507697
HALLMARK_IL2_STAT5_SIGNALING,Ovarian Serous Cystadenocarcinoma,0.012913403223996145
HALLMARK_IL2_STAT5_SIGNALING,Brain Lower Grade Glioma,0.007997544745487039
HALLMARK_IL2_STAT5_SIGNALING,Skin Cutaneous Melanoma,0.016511788042029796
HALLMARK_IL2_STAT5_SIGNALING,Lung Adenocarcinoma,0.01381754272887692
HALLMARK_IL2_STAT5_SIGNALING,Kidney Renal Clear Cell Carcinoma,0.006617160751842521
HALLMARK_IL2_STAT5_SIGNALING,Colon Adenocarcinoma,0.01570397765441084
HALLMARK_IL2_STAT5_SIGNALING,Uterine Corpus Endometrial Carcinoma,0.00819626311386123
HALLMARK_IL2_STAT5_SIGNALING,Head and Neck Squamous Cell Carcinoma,0.01706892881296611
HALLMARK_IL2_STAT5_SIGNALING,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.010706330591982071
HALLMARK_IL6_JAK_STAT3_SIGNALING,Kidney Renal Papillary Cell Carcinoma,0.004304899930470873
HALLMARK_IL6_JAK_STAT3_SIGNALING,Thyroid Carcinoma,1.0394931516858816e-05
HALLMARK_IL6_JAK_STAT3_SIGNALING,Liver Hepatocellular Carcinoma,0.014807196929305854
HALLMARK_IL6_JAK_STAT3_SIGNALING,Breast Invasive Carcinoma,0.004474223014261208
HALLMARK_IL6_JAK_STAT3_SIGNALING,Prostate Adenocarcinoma,0.0006961971581175592
HALLMARK_IL6_JAK_STAT3_SIGNALING,Bladder Urothelial Carcinoma,0.018672922576362404
HALLMARK_IL6_JAK_STAT3_SIGNALING,Stomach Adenocarcinoma,0.008419051733367289
HALLMARK_IL6_JAK_STAT3_SIGNALING,Lung Squamous Cell Carcinoma,0.014742007211281027
HALLMARK_IL6_JAK_STAT3_SIGNALING,Ovarian Serous Cystadenocarcinoma,0.012082705122914473
HALLMARK_IL6_JAK_STAT3_SIGNALING,Brain Lower Grade Glioma,0.004535329509574126
HALLMARK_IL6_JAK_STAT3_SIGNALING,Skin Cutaneous Melanoma,0.014694992408371488
HALLMARK_IL6_JAK_STAT3_SIGNALING,Lung Adenocarcinoma,0.013228775245326996
HALLMARK_IL6_JAK_STAT3_SIGNALING,Kidney Renal Clear Cell Carcinoma,0.0031194213863748655
HALLMARK_IL6_JAK_STAT3_SIGNALING,Colon Adenocarcinoma,0.010594058031820525
HALLMARK_IL6_JAK_STAT3_SIGNALING,Uterine Corpus Endometrial Carcinoma,0.009475956470276681
HALLMARK_IL6_JAK_STAT3_SIGNALING,Head and Neck Squamous Cell Carcinoma,0.02024783634292292
HALLMARK_IL6_JAK_STAT3_SIGNALING,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.0125004171918739
HALLMARK_INFLAMMATORY_RESPONSE,Kidney Renal Papillary Cell Carcinoma,0.008613141969312265
HALLMARK_INFLAMMATORY_RESPONSE,Thyroid Carcinoma,0.0008782057091593718
HALLMARK_INFLAMMATORY_RESPONSE,Liver Hepatocellular Carcinoma,0.017660114122292115
HALLMARK_INFLAMMATORY_RESPONSE,Breast Invasive Carcinoma,0.007929904135624565
HALLMARK_INFLAMMATORY_RESPONSE,Prostate Adenocarcinoma,0.001645224121312707
HALLMARK_INFLAMMATORY_RESPONSE,Bladder Urothelial Carcinoma,0.034493801437732986
HALLMARK_INFLAMMATORY_RESPONSE,Stomach Adenocarcinoma,0.03402654561155862
HALLMARK_INFLAMMATORY_RESPONSE,Lung Squamous Cell Carcinoma,0.0268930172217291
HALLMARK_INFLAMMATORY_RESPONSE,Ovarian Serous Cystadenocarcinoma,0.025925081601783438
HALLMARK_INFLAMMATORY_RESPONSE,Brain Lower Grade Glioma,0.007379143096763652
HALLMARK_INFLAMMATORY_RESPONSE,Skin Cutaneous Melanoma,0.03035410499571136
HALLMARK_INFLAMMATORY_RESPONSE,Lung Adenocarcinoma,0.02262371571266395
HALLMARK_INFLAMMATORY_RESPONSE,Kidney Renal Clear Cell Carcinoma,0.015819042170277
HALLMARK_INFLAMMATORY_RESPONSE,Colon Adenocarcinoma,0.027098334593119056
HALLMARK_INFLAMMATORY_RESPONSE,Uterine Corpus Endometrial Carcinoma,0.01002945654781014
HALLMARK_INFLAMMATORY_RESPONSE,Head and Neck Squamous Cell Carcinoma,0.03782171846041219
HALLMARK_INFLAMMATORY_RESPONSE,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.02533949553966522
HALLMARK_INTERFERON_ALPHA_RESPONSE,Kidney Renal Papillary Cell Carcinoma,-1.3888665503919428e-05
HALLMARK_INTERFERON_ALPHA_RESPONSE,Thyroid Carcinoma,1.555003903128578e-05
HALLMARK_INTERFERON_ALPHA_RESPONSE,Liver Hepatocellular Carcinoma,0.003542702434576994
HALLMARK_INTERFERON_ALPHA_RESPONSE,Breast Invasive Carcinoma,0.0009811760829363358
HALLMARK_INTERFERON_ALPHA_RESPONSE,Prostate Adenocarcinoma,0.00027320546306710376
HALLMARK_INTERFERON_ALPHA_RESPONSE,Bladder Urothelial Carcinoma,0.005513681040151264
HALLMARK_INTERFERON_ALPHA_RESPONSE,Stomach Adenocarcinoma,0.002923445930813151
HALLMARK_INTERFERON_ALPHA_RESPONSE,Lung Squamous Cell Carcinoma,0.002558892559352377
HALLMARK_INTERFERON_ALPHA_RESPONSE,Ovarian Serous Cystadenocarcinoma,0.0016154602131440488
HALLMARK_INTERFERON_ALPHA_RESPONSE,Brain Lower Grade Glioma,0.0007932766152794702
HALLMARK_INTERFERON_ALPHA_RESPONSE,Skin Cutaneous Melanoma,0.006727115037953068
HALLMARK_INTERFERON_ALPHA_RESPONSE,Lung Adenocarcinoma,0.0030672244760414414
HALLMARK_INTERFERON_ALPHA_RESPONSE,Kidney Renal Clear Cell Carcinoma,0.000487750814511223
HALLMARK_INTERFERON_ALPHA_RESPONSE,Colon Adenocarcinoma,0.004303235269111133
HALLMARK_INTERFERON_ALPHA_RESPONSE,Uterine Corpus Endometrial Carcinoma,0.0022704729925936973
HALLMARK_INTERFERON_ALPHA_RESPONSE,Head and Neck Squamous Cell Carcinoma,0.0060390124768775035
HALLMARK_INTERFERON_ALPHA_RESPONSE,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.0048412252827124275
HALLMARK_INTERFERON_GAMMA_RESPONSE,Kidney Renal Papillary Cell Carcinoma,0.008869110334647101
HALLMARK_INTERFERON_GAMMA_RESPONSE,Thyroid Carcinoma,0.0012310627085918686
HALLMARK_INTERFERON_GAMMA_RESPONSE,Liver Hepatocellular Carcinoma,0.01067823472394771
HALLMARK_INTERFERON_GAMMA_RESPONSE,Breast Invasive Carcinoma,0.006877848592348778
HALLMARK_INTERFERON_GAMMA_RESPONSE,Prostate Adenocarcinoma,0.0013432689092524052
HALLMARK_INTERFERON_GAMMA_RESPONSE,Bladder Urothelial Carcinoma,0.027824585384840672
HALLMARK_INTERFERON_GAMMA_RESPONSE,Stomach Adenocarcinoma,0.018970388868169975
HALLMARK_INTERFERON_GAMMA_RESPONSE,Lung Squamous Cell Carcinoma,0.019253899473268943
HALLMARK_INTERFERON_GAMMA_RESPONSE,Ovarian Serous Cystadenocarcinoma,0.01280678670323312
HALLMARK_INTERFERON_GAMMA_RESPONSE,Brain Lower Grade Glioma,0.008643332605813913
HALLMARK_INTERFERON_GAMMA_RESPONSE,Skin Cutaneous Melanoma,0.02414415825852396
HALLMARK_INTERFERON_GAMMA_RESPONSE,Lung Adenocarcinoma,0.01417360371755182
HALLMARK_INTERFERON_GAMMA_RESPONSE,Kidney Renal Clear Cell Carcinoma,0.006398298877936126
HALLMARK_INTERFERON_GAMMA_RESPONSE,Colon Adenocarcinoma,0.014152690190136647
HALLMARK_INTERFERON_GAMMA_RESPONSE,Uterine Corpus Endometrial Carcinoma,0.0073286691900569965
HALLMARK_INTERFERON_GAMMA_RESPONSE,Head and Neck Squamous Cell Carcinoma,0.024130076290992265
HALLMARK_INTERFERON_GAMMA_RESPONSE,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.023250424157489426
HALLMARK_KRAS_SIGNALING_DN,Kidney Renal Papillary Cell Carcinoma,0.006284534304988265
HALLMARK_KRAS_SIGNALING_DN,Thyroid Carcinoma,0.002651993574743921
HALLMARK_KRAS_SIGNALING_DN,Liver Hepatocellular Carcinoma,0.006831861969415043
HALLMARK_KRAS_SIGNALING_DN,Breast Invasive Carcinoma,0.008610478073930982
HALLMARK_KRAS_SIGNALING_DN,Prostate Adenocarcinoma,0.0013340536842143037
HALLMARK_KRAS_SIGNALING_DN,Bladder Urothelial Carcinoma,0.03031431342514974
HALLMARK_KRAS_SIGNALING_DN,Stomach Adenocarcinoma,0.016089891582732708
HALLMARK_KRAS_SIGNALING_DN,Lung Squamous Cell Carcinoma,0.022926670095046297
HALLMARK_KRAS_SIGNALING_DN,Ovarian Serous Cystadenocarcinoma,0.015806056128212488
HALLMARK_KRAS_SIGNALING_DN,Brain Lower Grade Glioma,0.007259207740881057
HALLMARK_KRAS_SIGNALING_DN,Skin Cutaneous Melanoma,0.023220644615958897
HALLMARK_KRAS_SIGNALING_DN,Lung Adenocarcinoma,0.020570825160191163
HALLMARK_KRAS_SIGNALING_DN,Kidney Renal Clear Cell Carcinoma,0.009343572316261428
HALLMARK_KRAS_SIGNALING_DN,Colon Adenocarcinoma,0.02115717828273773
HALLMARK_KRAS_SIGNALING_DN,Uterine Corpus Endometrial Carcinoma,0.006331804517710043
HALLMARK_KRAS_SIGNALING_DN,Head and Neck Squamous Cell Carcinoma,0.021222638796428737
HALLMARK_KRAS_SIGNALING_DN,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.02104141445322471
HALLMARK_KRAS_SIGNALING_UP,Kidney Renal Papillary Cell Carcinoma,0.005063382172388653
HALLMARK_KRAS_SIGNALING_UP,Thyroid Carcinoma,0.001600951887667175
HALLMARK_KRAS_SIGNALING_UP,Liver Hepatocellular Carcinoma,0.007173709445999521
HALLMARK_KRAS_SIGNALING_UP,Breast Invasive Carcinoma,0.006982097092018652
HALLMARK_KRAS_SIGNALING_UP,Prostate Adenocarcinoma,0.0008422422579036713
HALLMARK_KRAS_SIGNALING_UP,Bladder Urothelial Carcinoma,0.024544784430880772
HALLMARK_KRAS_SIGNALING_UP,Stomach Adenocarcinoma,0.016911109621598187
HALLMARK_KRAS_SIGNALING_UP,Lung Squamous Cell Carcinoma,0.02160133851603907
HALLMARK_KRAS_SIGNALING_UP,Ovarian Serous Cystadenocarcinoma,0.020815761088138807
HALLMARK_KRAS_SIGNALING_UP,Brain Lower Grade Glioma,0.006642200398142761
HALLMARK_KRAS_SIGNALING_UP,Skin Cutaneous Melanoma,0.025649236800264652
HALLMARK_KRAS_SIGNALING_UP,Lung Adenocarcinoma,0.01563917323549511
HALLMARK_KRAS_SIGNALING_UP,Kidney Renal Clear Cell Carcinoma,0.012183840177380122
HALLMARK_KRAS_SIGNALING_UP,Colon Adenocarcinoma,0.017741761194623045
HALLMARK_KRAS_SIGNALING_UP,Uterine Corpus Endometrial Carcinoma,0.009789606501904224
HALLMARK_KRAS_SIGNALING_UP,Head and Neck Squamous Cell Carcinoma,0.018227521870947106
HALLMARK_KRAS_SIGNALING_UP,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.014313828132369305
HALLMARK_MITOTIC_SPINDLE,Kidney Renal Papillary Cell Carcinoma,0.002010770614958285
HALLMARK_MITOTIC_SPINDLE,Thyroid Carcinoma,0.0005268023264679008
HALLMARK_MITOTIC_SPINDLE,Liver Hepatocellular Carcinoma,0.0017611869513216361
HALLMARK_MITOTIC_SPINDLE,Breast Invasive Carcinoma,0.003577315085229138
HALLMARK_MITOTIC_SPINDLE,Prostate Adenocarcinoma,0.0007786069870697413
HALLMARK_MITOTIC_SPINDLE,Bladder Urothelial Carcinoma,0.013761968286324377
HALLMARK_MITOTIC_SPINDLE,Stomach Adenocarcinoma,0.011973336759680386
HALLMARK_MITOTIC_SPINDLE,Lung Squamous Cell Carcinoma,0.007826741788528536
HALLMARK_MITOTIC_SPINDLE,Ovarian Serous Cystadenocarcinoma,0.006214939593082636
HALLMARK_MITOTIC_SPINDLE,Brain Lower Grade Glioma,0.0038107744796806566
HALLMARK_MITOTIC_SPINDLE,Skin Cutaneous Melanoma,0.01118558176663682
HALLMARK_MITOTIC_SPINDLE,Lung Adenocarcinoma,0.0063282456368984885
HALLMARK_MITOTIC_SPINDLE,Kidney Renal Clear Cell Carcinoma,0.0007895726739214015
HALLMARK_MITOTIC_SPINDLE,Colon Adenocarcinoma,0.007491199183822866
HALLMARK_MITOTIC_SPINDLE,Uterine Corpus Endometrial Carcinoma,0.004068622909487424
HALLMARK_MITOTIC_SPINDLE,Head and Neck Squamous Cell Carcinoma,0.007868475917027062
HALLMARK_MITOTIC_SPINDLE,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.012049749019471066
HALLMARK_MTORC1_SIGNALING,Kidney Renal Papillary Cell Carcinoma,0.009486294027415593
HALLMARK_MTORC1_SIGNALING,Thyroid Carcinoma,0.0017931062304838113
HALLMARK_MTORC1_SIGNALING,Liver Hepatocellular Carcinoma,0.014671259840649131
HALLMARK_MTORC1_SIGNALING,Breast Invasive Carcinoma,0.0076631215284133245
HALLMARK_MTORC1_SIGNALING,Prostate Adenocarcinoma,0.001440034592091589
HALLMARK_MTORC1_SIGNALING,Bladder Urothelial Carcinoma,0.02759450111112276
HALLMARK_MTORC1_SIGNALING,Stomach Adenocarcinoma,0.015804994501250547
HALLMARK_MTORC1_SIGNALING,Lung Squamous Cell Carcinoma,0.02526169374880991
HALLMARK_MTORC1_SIGNALING,Ovarian Serous Cystadenocarcinoma,0.01496260814524406
HALLMARK_MTORC1_SIGNALING,Brain Lower Grade Glioma,0.008369521513519829
HALLMARK_MTORC1_SIGNALING,Skin Cutaneous Melanoma,0.02113574639534861
HALLMARK_MTORC1_SIGNALING,Lung Adenocarcinoma,0.017232578363678742
HALLMARK_MTORC1_SIGNALING,Kidney Renal Clear Cell Carcinoma,0.0063156357980691195
HALLMARK_MTORC1_SIGNALING,Colon Adenocarcinoma,0.012415267561989069
HALLMARK_MTORC1_SIGNALING,Uterine Corpus Endometrial Carcinoma,0.010376307142354813
HALLMARK_MTORC1_SIGNALING,Head and Neck Squamous Cell Carcinoma,0.022807048480522805
HALLMARK_MTORC1_SIGNALING,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.02133326698433271
HALLMARK_MYC_TARGETS_V1,Kidney Renal Papillary Cell Carcinoma,0.0013284705065151835
HALLMARK_MYC_TARGETS_V1,Thyroid Carcinoma,0.0021838990548117576
HALLMARK_MYC_TARGETS_V1,Liver Hepatocellular Carcinoma,0.012691488475980972
HALLMARK_MYC_TARGETS_V1,Breast Invasive Carcinoma,0.0030735042484116406
HALLMARK_MYC_TARGETS_V1,Prostate Adenocarcinoma,0.0008313729214008712
HALLMARK_MYC_TARGETS_V1,Bladder Urothelial Carcinoma,0.013878163573060242
HALLMARK_MYC_TARGETS_V1,Stomach Adenocarcinoma,0.006038807974874305
HALLMARK_MYC_TARGETS_V1,Lung Squamous Cell Carcinoma,0.01141222140810696
HALLMARK_MYC_TARGETS_V1,Ovarian Serous Cystadenocarcinoma,0.003736555953523979
HALLMARK_MYC_TARGETS_V1,Brain Lower Grade Glioma,0.004774270604787812
HALLMARK_MYC_TARGETS_V1,Skin Cutaneous Melanoma,0.012569946312645786
HALLMARK_MYC_TARGETS_V1,Lung Adenocarcinoma,0.006432674894320112
HALLMARK_MYC_TARGETS_V1,Kidney Renal Clear Cell Carcinoma,0.0022732089918393373
HALLMARK_MYC_TARGETS_V1,Colon Adenocarcinoma,0.006971405596039365
HALLMARK_MYC_TARGETS_V1,Uterine Corpus Endometrial Carcinoma,0.005680904639149581
HALLMARK_MYC_TARGETS_V1,Head and Neck Squamous Cell Carcinoma,0.00795912769845294
HALLMARK_MYC_TARGETS_V1,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.009513756199316553
HALLMARK_MYC_TARGETS_V2,Kidney Renal Papillary Cell Carcinoma,0.001706148230548521
HALLMARK_MYC_TARGETS_V2,Thyroid Carcinoma,0.0004788195799020203
HALLMARK_MYC_TARGETS_V2,Liver Hepatocellular Carcinoma,0.0030999826120648886
HALLMARK_MYC_TARGETS_V2,Breast Invasive Carcinoma,0.001147708934139563
HALLMARK_MYC_TARGETS_V2,Prostate Adenocarcinoma,0.00020900573619626176
HALLMARK_MYC_TARGETS_V2,Bladder Urothelial Carcinoma,0.005678439605109109
HALLMARK_MYC_TARGETS_V2,Stomach Adenocarcinoma,0.0016573043476552306
HALLMARK_MYC_TARGETS_V2,Lung Squamous Cell Carcinoma,0.0008661834380790268
HALLMARK_MYC_TARGETS_V2,Ovarian Serous Cystadenocarcinoma,0.0012691294150566357
HALLMARK_MYC_TARGETS_V2,Brain Lower Grade Glioma,0.002778588408119442
HALLMARK_MYC_TARGETS_V2,Skin Cutaneous Melanoma,0.0035286252247697545
HALLMARK_MYC_TARGETS_V2,Lung Adenocarcinoma,0.0021718759575559575
HALLMARK_MYC_TARGETS_V2,Kidney Renal Clear Cell Carcinoma,0.004718592298718583
HALLMARK_MYC_TARGETS_V2,Colon Adenocarcinoma,0.002228654487475895
HALLMARK_MYC_TARGETS_V2,Uterine Corpus Endometrial Carcinoma,0.003567472918562914
HALLMARK_MYC_TARGETS_V2,Head and Neck Squamous Cell Carcinoma,0.003233645425230125
HALLMARK_MYC_TARGETS_V2,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.004293658543716786
HALLMARK_MYOGENESIS,Kidney Renal Papillary Cell Carcinoma,0.0072275519720165216
HALLMARK_MYOGENESIS,Thyroid Carcinoma,0.0012978001921014313
HALLMARK_MYOGENESIS,Liver Hepatocellular Carcinoma,0.014000955759318357
HALLMARK_MYOGENESIS,Breast Invasive Carcinoma,0.005289387418993652
HALLMARK_MYOGENESIS,Prostate Adenocarcinoma,0.0008640926097178715
HALLMARK_MYOGENESIS,Bladder Urothelial Carcinoma,0.0228424516899269
HALLMARK_MYOGENESIS,Stomach Adenocarcinoma,0.01207561065369812
HALLMARK_MYOGENESIS,Lung Squamous Cell Carcinoma,0.013936149870890513
HALLMARK_MYOGENESIS,Ovarian Serous Cystadenocarcinoma,0.012108312876070348
HALLMARK_MYOGENESIS,Brain Lower Grade Glioma,0.0035386590242659556
HALLMARK_MYOGENESIS,Skin Cutaneous Melanoma,0.014992963943919557
HALLMARK_MYOGENESIS,Lung Adenocarcinoma,0.011077574232853249
HALLMARK_MYOGENESIS,Kidney Renal Clear Cell Carcinoma,0.0087372012837575
HALLMARK_MYOGENESIS,Colon Adenocarcinoma,0.019483297086479678
HALLMARK_MYOGENESIS,Uterine Corpus Endometrial Carcinoma,0.007743478023795808
HALLMARK_MYOGENESIS,Head and Neck Squamous Cell Carcinoma,0.017540854442543163
HALLMARK_MYOGENESIS,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.01669124356724999
HALLMARK_NOTCH_SIGNALING,Kidney Renal Papillary Cell Carcinoma,0.00044757884046260356
HALLMARK_NOTCH_SIGNALING,Thyroid Carcinoma,-0.00033644405616955786
HALLMARK_NOTCH_SIGNALING,Liver Hepatocellular Carcinoma,-0.0008026723898679089
HALLMARK_NOTCH_SIGNALING,Breast Invasive Carcinoma,0.0007806041835387689
HALLMARK_NOTCH_SIGNALING,Prostate Adenocarcinoma,0.00019780450737195396
HALLMARK_NOTCH_SIGNALING,Bladder Urothelial Carcinoma,0.0026416228165798026
HALLMARK_NOTCH_SIGNALING,Stomach Adenocarcinoma,0.002304854362295694
HALLMARK_NOTCH_SIGNALING,Lung Squamous Cell Carcinoma,0.0015819630628910232
HALLMARK_NOTCH_SIGNALING,Ovarian Serous Cystadenocarcinoma,0.0011860551359641925
HALLMARK_NOTCH_SIGNALING,Brain Lower Grade Glioma,0.0008070202196768684
HALLMARK_NOTCH_SIGNALING,Skin Cutaneous Melanoma,0.0026588993906205617
HALLMARK_NOTCH_SIGNALING,Lung Adenocarcinoma,0.0015457958491576717
HALLMARK_NOTCH_SIGNALING,Kidney Renal Clear Cell Carcinoma,0.0018514390117847057
HALLMARK_NOTCH_SIGNALING,Colon Adenocarcinoma,0.001561326959659426
HALLMARK_NOTCH_SIGNALING,Uterine Corpus Endometrial Carcinoma,0.001668808869454963
HALLMARK_NOTCH_SIGNALING,Head and Neck Squamous Cell Carcinoma,0.0014511923196957044
HALLMARK_NOTCH_SIGNALING,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.0021361241286451003
HALLMARK_OXIDATIVE_PHOSPHORYLATION,Kidney Renal Papillary Cell Carcinoma,0.0013389039431907501
HALLMARK_OXIDATIVE_PHOSPHORYLATION,Thyroid Carcinoma,-0.0006324752911248028
HALLMARK_OXIDATIVE_PHOSPHORYLATION,Liver Hepatocellular Carcinoma,0.001771643929077249
HALLMARK_OXIDATIVE_PHOSPHORYLATION,Breast Invasive Carcinoma,0.0009837503070393439
HALLMARK_OXIDATIVE_PHOSPHORYLATION,Prostate Adenocarcinoma,0.00027015333272557406
HALLMARK_OXIDATIVE_PHOSPHORYLATION,Bladder Urothelial Carcinoma,0.005401522909778189
HALLMARK_OXIDATIVE_PHOSPHORYLATION,Stomach Adenocarcinoma,0.0042768117897494795
HALLMARK_OXIDATIVE_PHOSPHORYLATION,Lung Squamous Cell Carcinoma,0.004894804828663469
HALLMARK_OXIDATIVE_PHOSPHORYLATION,Ovarian Serous Cystadenocarcinoma,0.004625122198418064
HALLMARK_OXIDATIVE_PHOSPHORYLATION,Brain Lower Grade Glioma,0.002217750065952262
HALLMARK_OXIDATIVE_PHOSPHORYLATION,Skin Cutaneous Melanoma,0.0030915644580589373
HALLMARK_OXIDATIVE_PHOSPHORYLATION,Lung Adenocarcinoma,0.004377659739593931
HALLMARK_OXIDATIVE_PHOSPHORYLATION,Kidney Renal Clear Cell Carcinoma,-0.0002925668026392492
HALLMARK_OXIDATIVE_PHOSPHORYLATION,Colon Adenocarcinoma,0.00385986431486231
HALLMARK_OXIDATIVE_PHOSPHORYLATION,Uterine Corpus Endometrial Carcinoma,0.000202645189474171
HALLMARK_OXIDATIVE_PHOSPHORYLATION,Head and Neck Squamous Cell Carcinoma,0.003549052207603065
HALLMARK_OXIDATIVE_PHOSPHORYLATION,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.0023136694187467833
HALLMARK_P53_PATHWAY,Kidney Renal Papillary Cell Carcinoma,0.005197264513203631
HALLMARK_P53_PATHWAY,Thyroid Carcinoma,0.0009186780926856077
HALLMARK_P53_PATHWAY,Liver Hepatocellular Carcinoma,0.012567810628616305
HALLMARK_P53_PATHWAY,Breast Invasive Carcinoma,0.0037333514584131757
HALLMARK_P53_PATHWAY,Prostate Adenocarcinoma,0.000747572899226079
HALLMARK_P53_PATHWAY,Bladder Urothelial Carcinoma,0.020586405401491426
HALLMARK_P53_PATHWAY,Stomach Adenocarcinoma,0.006373797980777562
HALLMARK_P53_PATHWAY,Lung Squamous Cell Carcinoma,0.014072513293141275
HALLMARK_P53_PATHWAY,Ovarian Serous Cystadenocarcinoma,0.009747267841699724
HALLMARK_P53_PATHWAY,Brain Lower Grade Glioma,0.0036969778874863745
HALLMARK_P53_PATHWAY,Skin Cutaneous Melanoma,0.013232056714997142
HALLMARK_P53_PATHWAY,Lung Adenocarcinoma,0.013162198532548663
HALLMARK_P53_PATHWAY,Kidney Renal Clear Cell Carcinoma,0.010215039281890947
HALLMARK_P53_PATHWAY,Colon Adenocarcinoma,0.014465296966176378
HALLMARK_P53_PATHWAY,Uterine Corpus Endometrial Carcinoma,0.0039920440435512235
HALLMARK_P53_PATHWAY,Head and Neck Squamous Cell Carcinoma,0.01983822957815856
HALLMARK_P53_PATHWAY,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.012486447556452302
HALLMARK_PANCREAS_BETA_CELLS,Kidney Renal Papillary Cell Carcinoma,0.004055791374948353
HALLMARK_PANCREAS_BETA_CELLS,Thyroid Carcinoma,0.0002327849919145721
HALLMARK_PANCREAS_BETA_CELLS,Liver Hepatocellular Carcinoma,0.0003204299259809473
HALLMARK_PANCREAS_BETA_CELLS,Breast Invasive Carcinoma,0.001288668150442912
HALLMARK_PANCREAS_BETA_CELLS,Prostate Adenocarcinoma,0.0005620790173457393
HALLMARK_PANCREAS_BETA_CELLS,Bladder Urothelial Carcinoma,0.005707448701051799
HALLMARK_PANCREAS_BETA_CELLS,Stomach Adenocarcinoma,0.0057714704804208705
HALLMARK_PANCREAS_BETA_CELLS,Lung Squamous Cell Carcinoma,0.0025145953457162973
HALLMARK_PANCREAS_BETA_CELLS,Ovarian Serous Cystadenocarcinoma,0.00026096855348616276
HALLMARK_PANCREAS_BETA_CELLS,Brain Lower Grade Glioma,0.002390087595674872
HALLMARK_PANCREAS_BETA_CELLS,Skin Cutaneous Melanoma,0.004930749840992799
HALLMARK_PANCREAS_BETA_CELLS,Lung Adenocarcinoma,0.006035953213552991
HALLMARK_PANCREAS_BETA_CELLS,Kidney Renal Clear Cell Carcinoma,0.00023419252381874368
HALLMARK_PANCREAS_BETA_CELLS,Colon Adenocarcinoma,0.005342386094822138
HALLMARK_PANCREAS_BETA_CELLS,Uterine Corpus Endometrial Carcinoma,0.0003363745033342247
HALLMARK_PANCREAS_BETA_CELLS,Head and Neck Squamous Cell Carcinoma,0.004291415199410486
HALLMARK_PANCREAS_BETA_CELLS,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.003861783228137278
HALLMARK_PEROXISOME,Kidney Renal Papillary Cell Carcinoma,0.002408554855546341
HALLMARK_PEROXISOME,Thyroid Carcinoma,0.0008986570364372268
HALLMARK_PEROXISOME,Liver Hepatocellular Carcinoma,0.0022515975783391597
HALLMARK_PEROXISOME,Breast Invasive Carcinoma,0.0023378509632660804
HALLMARK_PEROXISOME,Prostate Adenocarcinoma,0.0011581627248730402
HALLMARK_PEROXISOME,Bladder Urothelial Carcinoma,0.015700463120995302
HALLMARK_PEROXISOME,Stomach Adenocarcinoma,0.0117991016283158
HALLMARK_PEROXISOME,Lung Squamous Cell Carcinoma,0.012563016841231955
HALLMARK_PEROXISOME,Ovarian Serous Cystadenocarcinoma,0.0068744422903108
HALLMARK_PEROXISOME,Brain Lower Grade Glioma,0.004819747523189655
HALLMARK_PEROXISOME,Skin Cutaneous Melanoma,0.010775200146031661
HALLMARK_PEROXISOME,Lung Adenocarcinoma,0.013183999403158776
HALLMARK_PEROXISOME,Kidney Renal Clear Cell Carcinoma,0.0038651050655887586
HALLMARK_PEROXISOME,Colon Adenocarcinoma,0.013077441834685788
HALLMARK_PEROXISOME,Uterine Corpus Endometrial Carcinoma,0.005593288153672887
HALLMARK_PEROXISOME,Head and Neck Squamous Cell Carcinoma,0.011074289755167699
HALLMARK_PEROXISOME,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.013710860284891994
HALLMARK_PI3K_AKT_MTOR_SIGNALING,Kidney Renal Papillary Cell Carcinoma,0.005345272811307722
HALLMARK_PI3K_AKT_MTOR_SIGNALING,Thyroid Carcinoma,0.0009037879464978506
HALLMARK_PI3K_AKT_MTOR_SIGNALING,Liver Hepatocellular Carcinoma,0.013413215420842017
HALLMARK_PI3K_AKT_MTOR_SIGNALING,Breast Invasive Carcinoma,0.004351064198426851
HALLMARK_PI3K_AKT_MTOR_SIGNALING,Prostate Adenocarcinoma,0.0005028383540437444
HALLMARK_PI3K_AKT_MTOR_SIGNALING,Bladder Urothelial Carcinoma,0.02491621218713048
HALLMARK_PI3K_AKT_MTOR_SIGNALING,Stomach Adenocarcinoma,0.015379939139285093
HALLMARK_PI3K_AKT_MTOR_SIGNALING,Lung Squamous Cell Carcinoma,0.01875464507028708
HALLMARK_PI3K_AKT_MTOR_SIGNALING,Ovarian Serous Cystadenocarcinoma,0.015411393477549029
HALLMARK_PI3K_AKT_MTOR_SIGNALING,Brain Lower Grade Glioma,0.010063642428920438
HALLMARK_PI3K_AKT_MTOR_SIGNALING,Skin Cutaneous Melanoma,0.025406017044443806
HALLMARK_PI3K_AKT_MTOR_SIGNALING,Lung Adenocarcinoma,0.01855418596029511
HALLMARK_PI3K_AKT_MTOR_SIGNALING,Kidney Renal Clear Cell Carcinoma,0.0017633403809024673
HALLMARK_PI3K_AKT_MTOR_SIGNALING,Colon Adenocarcinoma,0.01842601172202408
HALLMARK_PI3K_AKT_MTOR_SIGNALING,Uterine Corpus Endometrial Carcinoma,0.0051334173431392734
HALLMARK_PI3K_AKT_MTOR_SIGNALING,Head and Neck Squamous Cell Carcinoma,0.017677691382199934
HALLMARK_PI3K_AKT_MTOR_SIGNALING,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.018842774169011558
HALLMARK_PROTEIN_SECRETION,Kidney Renal Papillary Cell Carcinoma,-0.00010371078219897911
HALLMARK_PROTEIN_SECRETION,Thyroid Carcinoma,-0.0002616647969592774
HALLMARK_PROTEIN_SECRETION,Liver Hepatocellular Carcinoma,0.00035976012724072695
HALLMARK_PROTEIN_SECRETION,Breast Invasive Carcinoma,0.001668586461206184
HALLMARK_PROTEIN_SECRETION,Prostate Adenocarcinoma,0.00012044163364815141
HALLMARK_PROTEIN_SECRETION,Bladder Urothelial Carcinoma,0.005680745073727201
HALLMARK_PROTEIN_SECRETION,Stomach Adenocarcinoma,0.0064222936675937484
HALLMARK_PROTEIN_SECRETION,Lung Squamous Cell Carcinoma,0.0056781636230375685
HALLMARK_PROTEIN_SECRETION,Ovarian Serous Cystadenocarcinoma,0.0023726945302972704
HALLMARK_PROTEIN_SECRETION,Brain Lower Grade Glioma,0.0013851524495998913
HALLMARK_PROTEIN_SECRETION,Skin Cutaneous Melanoma,0.00415974335235032
HALLMARK_PROTEIN_SECRETION,Lung Adenocarcinoma,0.005543778473945183
HALLMARK_PROTEIN_SECRETION,Kidney Renal Clear Cell Carcinoma,-0.0006124580938082658
HALLMARK_PROTEIN_SECRETION,Colon Adenocarcinoma,0.005133747491350138
HALLMARK_PROTEIN_SECRETION,Uterine Corpus Endometrial Carcinoma,0.002464228003696889
HALLMARK_PROTEIN_SECRETION,Head and Neck Squamous Cell Carcinoma,0.0064883125463718
HALLMARK_PROTEIN_SECRETION,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.00574591896750711
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,Kidney Renal Papillary Cell Carcinoma,0.0038448655094619035
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,Thyroid Carcinoma,-0.00012235486541282148
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,Liver Hepatocellular Carcinoma,0.004484613898839918
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,Breast Invasive Carcinoma,0.002207957528685428
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,Prostate Adenocarcinoma,0.0009733022946375802
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,Bladder Urothelial Carcinoma,0.010021910724425298
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,Stomach Adenocarcinoma,0.006907936803031889
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,Lung Squamous Cell Carcinoma,0.00874172262452757
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,Ovarian Serous Cystadenocarcinoma,0.004640744607839986
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,Brain Lower Grade Glioma,0.0035151462828330814
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,Skin Cutaneous Melanoma,0.00941208228796373
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,Lung Adenocarcinoma,0.006898744387011224
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,Kidney Renal Clear Cell Carcinoma,0.0041787035877887905
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,Colon Adenocarcinoma,0.008515556575263216
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,Uterine Corpus Endometrial Carcinoma,0.004612925764018438
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,Head and Neck Squamous Cell Carcinoma,0.011376792585789209
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.00774343647740105
HALLMARK_SPERMATOGENESIS,Kidney Renal Papillary Cell Carcinoma,0.0016669058682398097
HALLMARK_SPERMATOGENESIS,Thyroid Carcinoma,0.0005674632604826584
HALLMARK_SPERMATOGENESIS,Liver Hepatocellular Carcinoma,0.0045598024723329965
HALLMARK_SPERMATOGENESIS,Breast Invasive Carcinoma,0.00257902791346879
HALLMARK_SPERMATOGENESIS,Prostate Adenocarcinoma,0.00031547218286355884
HALLMARK_SPERMATOGENESIS,Bladder Urothelial Carcinoma,0.009849317818490865
HALLMARK_SPERMATOGENESIS,Stomach Adenocarcinoma,0.006166152945836456
HALLMARK_SPERMATOGENESIS,Lung Squamous Cell Carcinoma,0.009968021001922822
HALLMARK_SPERMATOGENESIS,Ovarian Serous Cystadenocarcinoma,0.004511851588291904
HALLMARK_SPERMATOGENESIS,Brain Lower Grade Glioma,0.0034921645189515014
HALLMARK_SPERMATOGENESIS,Skin Cutaneous Melanoma,0.008849164903090113
HALLMARK_SPERMATOGENESIS,Lung Adenocarcinoma,0.009034850385118776
HALLMARK_SPERMATOGENESIS,Kidney Renal Clear Cell Carcinoma,-0.001680131520216277
HALLMARK_SPERMATOGENESIS,Colon Adenocarcinoma,0.005655681962352932
HALLMARK_SPERMATOGENESIS,Uterine Corpus Endometrial Carcinoma,0.00430858096213117
HALLMARK_SPERMATOGENESIS,Head and Neck Squamous Cell Carcinoma,0.007254792863342352
HALLMARK_SPERMATOGENESIS,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.005919278372417808
HALLMARK_TGF_BETA_SIGNALING,Kidney Renal Papillary Cell Carcinoma,0.003218401460884013
HALLMARK_TGF_BETA_SIGNALING,Thyroid Carcinoma,0.00013539421118118484
HALLMARK_TGF_BETA_SIGNALING,Liver Hepatocellular Carcinoma,0.003362162001816571
HALLMARK_TGF_BETA_SIGNALING,Breast Invasive Carcinoma,0.0011739191554730965
HALLMARK_TGF_BETA_SIGNALING,Prostate Adenocarcinoma,5.079171737360844e-05
HALLMARK_TGF_BETA_SIGNALING,Bladder Urothelial Carcinoma,0.008983161622006807
HALLMARK_TGF_BETA_SIGNALING,Stomach Adenocarcinoma,0.006552984478197766
HALLMARK_TGF_BETA_SIGNALING,Lung Squamous Cell Carcinoma,0.004980294461792889
HALLMARK_TGF_BETA_SIGNALING,Ovarian Serous Cystadenocarcinoma,0.003768949417332501
HALLMARK_TGF_BETA_SIGNALING,Brain Lower Grade Glioma,0.0023939414679291725
HALLMARK_TGF_BETA_SIGNALING,Skin Cutaneous Melanoma,0.0042070527092823665
HALLMARK_TGF_BETA_SIGNALING,Lung Adenocarcinoma,0.005021358939682164
HALLMARK_TGF_BETA_SIGNALING,Kidney Renal Clear Cell Carcinoma,0.0057608544482634525
HALLMARK_TGF_BETA_SIGNALING,Colon Adenocarcinoma,0.010520411444746941
HALLMARK_TGF_BETA_SIGNALING,Uterine Corpus Endometrial Carcinoma,0.0029237444489151666
HALLMARK_TGF_BETA_SIGNALING,Head and Neck Squamous Cell Carcinoma,0.010909281466818055
HALLMARK_TGF_BETA_SIGNALING,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.005299290838566717
HALLMARK_TNFA_SIGNALING_VIA_NFKB,Kidney Renal Papillary Cell Carcinoma,0.006262771991768823
HALLMARK_TNFA_SIGNALING_VIA_NFKB,Thyroid Carcinoma,0.0009297752075574605
HALLMARK_TNFA_SIGNALING_VIA_NFKB,Liver Hepatocellular Carcinoma,0.011500658772629457
HALLMARK_TNFA_SIGNALING_VIA_NFKB,Breast Invasive Carcinoma,0.006123082465041124
HALLMARK_TNFA_SIGNALING_VIA_NFKB,Prostate Adenocarcinoma,0.001626748069891798
HALLMARK_TNFA_SIGNALING_VIA_NFKB,Bladder Urothelial Carcinoma,0.027399116239083997
HALLMARK_TNFA_SIGNALING_VIA_NFKB,Stomach Adenocarcinoma,0.018315425693338005
HALLMARK_TNFA_SIGNALING_VIA_NFKB,Lung Squamous Cell Carcinoma,0.024633746084845788
HALLMARK_TNFA_SIGNALING_VIA_NFKB,Ovarian Serous Cystadenocarcinoma,0.020124815952718533
HALLMARK_TNFA_SIGNALING_VIA_NFKB,Brain Lower Grade Glioma,0.008804403578876074
HALLMARK_TNFA_SIGNALING_VIA_NFKB,Skin Cutaneous Melanoma,0.017307920610301442
HALLMARK_TNFA_SIGNALING_VIA_NFKB,Lung Adenocarcinoma,0.015554167557132759
HALLMARK_TNFA_SIGNALING_VIA_NFKB,Kidney Renal Clear Cell Carcinoma,0.018467755369268934
HALLMARK_TNFA_SIGNALING_VIA_NFKB,Colon Adenocarcinoma,0.01810953672414639
HALLMARK_TNFA_SIGNALING_VIA_NFKB,Uterine Corpus Endometrial Carcinoma,0.006695091604276305
HALLMARK_TNFA_SIGNALING_VIA_NFKB,Head and Neck Squamous Cell Carcinoma,0.03298468721397028
HALLMARK_TNFA_SIGNALING_VIA_NFKB,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.022191916799003418
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,Kidney Renal Papillary Cell Carcinoma,0.004038256698365816
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,Thyroid Carcinoma,0.00015705027194185296
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,Liver Hepatocellular Carcinoma,0.0024089965345781782
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,Breast Invasive Carcinoma,0.001665262823291852
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,Prostate Adenocarcinoma,0.0007775868072881893
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,Bladder Urothelial Carcinoma,0.00802105221758892
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,Stomach Adenocarcinoma,0.004866702382235699
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,Lung Squamous Cell Carcinoma,0.004276377793398822
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,Ovarian Serous Cystadenocarcinoma,0.002712070915829501
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,Brain Lower Grade Glioma,0.0020624500757916555
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,Skin Cutaneous Melanoma,0.004547955203213938
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,Lung Adenocarcinoma,0.004323713027490206
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,Kidney Renal Clear Cell Carcinoma,0.004957049024792803
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,Colon Adenocarcinoma,0.006259020604816179
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,Uterine Corpus Endometrial Carcinoma,0.0024304292610073165
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,Head and Neck Squamous Cell Carcinoma,0.005340506431414982
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.004762892804362559
HALLMARK_UV_RESPONSE_DN,Kidney Renal Papillary Cell Carcinoma,0.004924154293297961
HALLMARK_UV_RESPONSE_DN,Thyroid Carcinoma,-8.010999722915525e-06
HALLMARK_UV_RESPONSE_DN,Liver Hepatocellular Carcinoma,0.008775821861203714
HALLMARK_UV_RESPONSE_DN,Breast Invasive Carcinoma,0.004650267931854685
HALLMARK_UV_RESPONSE_DN,Prostate Adenocarcinoma,0.0013540670265509765
HALLMARK_UV_RESPONSE_DN,Bladder Urothelial Carcinoma,0.03397039274422551
HALLMARK_UV_RESPONSE_DN,Stomach Adenocarcinoma,0.02323110898232029
HALLMARK_UV_RESPONSE_DN,Lung Squamous Cell Carcinoma,0.01539605866915017
HALLMARK_UV_RESPONSE_DN,Ovarian Serous Cystadenocarcinoma,0.015499826275887196
HALLMARK_UV_RESPONSE_DN,Brain Lower Grade Glioma,0.01164099559482663
HALLMARK_UV_RESPONSE_DN,Skin Cutaneous Melanoma,0.024271528763605277
HALLMARK_UV_RESPONSE_DN,Lung Adenocarcinoma,0.020912173802570454
HALLMARK_UV_RESPONSE_DN,Kidney Renal Clear Cell Carcinoma,0.00997030026064467
HALLMARK_UV_RESPONSE_DN,Colon Adenocarcinoma,0.017722278260267687
HALLMARK_UV_RESPONSE_DN,Uterine Corpus Endometrial Carcinoma,0.012354168083555505
HALLMARK_UV_RESPONSE_DN,Head and Neck Squamous Cell Carcinoma,0.019209015974538557
HALLMARK_UV_RESPONSE_DN,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.015655692910606207
HALLMARK_UV_RESPONSE_UP,Kidney Renal Papillary Cell Carcinoma,0.006697174524004851
HALLMARK_UV_RESPONSE_UP,Thyroid Carcinoma,0.001006396309557284
HALLMARK_UV_RESPONSE_UP,Liver Hepatocellular Carcinoma,0.007822431307001743
HALLMARK_UV_RESPONSE_UP,Breast Invasive Carcinoma,0.0057809224345327535
HALLMARK_UV_RESPONSE_UP,Prostate Adenocarcinoma,0.0011172608985143197
HALLMARK_UV_RESPONSE_UP,Bladder Urothelial Carcinoma,0.026115150342917903
HALLMARK_UV_RESPONSE_UP,Stomach Adenocarcinoma,0.011320890217733349
HALLMARK_UV_RESPONSE_UP,Lung Squamous Cell Carcinoma,0.016123370147059023
HALLMARK_UV_RESPONSE_UP,Ovarian Serous Cystadenocarcinoma,0.013098670652256695
HALLMARK_UV_RESPONSE_UP,Brain Lower Grade Glioma,0.004122200176750579
HALLMARK_UV_RESPONSE_UP,Skin Cutaneous Melanoma,0.017372674090414965
HALLMARK_UV_RESPONSE_UP,Lung Adenocarcinoma,0.014566055996038663
HALLMARK_UV_RESPONSE_UP,Kidney Renal Clear Cell Carcinoma,0.012384597584605184
HALLMARK_UV_RESPONSE_UP,Colon Adenocarcinoma,0.013656446023728942
HALLMARK_UV_RESPONSE_UP,Uterine Corpus Endometrial Carcinoma,0.009018592038592916
HALLMARK_UV_RESPONSE_UP,Head and Neck Squamous Cell Carcinoma,0.015660582520634958
HALLMARK_UV_RESPONSE_UP,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.012243453711271285
HALLMARK_WNT_BETA_CATENIN_SIGNALING,Kidney Renal Papillary Cell Carcinoma,0.0041666311084094295
HALLMARK_WNT_BETA_CATENIN_SIGNALING,Thyroid Carcinoma,0.0002211419188163463
HALLMARK_WNT_BETA_CATENIN_SIGNALING,Liver Hepatocellular Carcinoma,-0.0010785819783418638
HALLMARK_WNT_BETA_CATENIN_SIGNALING,Breast Invasive Carcinoma,0.0015329656955579197
HALLMARK_WNT_BETA_CATENIN_SIGNALING,Prostate Adenocarcinoma,0.00042866365627838523
HALLMARK_WNT_BETA_CATENIN_SIGNALING,Bladder Urothelial Carcinoma,0.006835999119969194
HALLMARK_WNT_BETA_CATENIN_SIGNALING,Stomach Adenocarcinoma,0.009139555631379226
HALLMARK_WNT_BETA_CATENIN_SIGNALING,Lung Squamous Cell Carcinoma,0.007589346749289239
HALLMARK_WNT_BETA_CATENIN_SIGNALING,Ovarian Serous Cystadenocarcinoma,0.005074730950208472
HALLMARK_WNT_BETA_CATENIN_SIGNALING,Brain Lower Grade Glioma,0.0018988440159846797
HALLMARK_WNT_BETA_CATENIN_SIGNALING,Skin Cutaneous Melanoma,0.005613079613375182
HALLMARK_WNT_BETA_CATENIN_SIGNALING,Lung Adenocarcinoma,0.010469039330017204
HALLMARK_WNT_BETA_CATENIN_SIGNALING,Kidney Renal Clear Cell Carcinoma,0.00284161908122208
HALLMARK_WNT_BETA_CATENIN_SIGNALING,Colon Adenocarcinoma,0.006976568424781426
HALLMARK_WNT_BETA_CATENIN_SIGNALING,Uterine Corpus Endometrial Carcinoma,0.003344254624477333
HALLMARK_WNT_BETA_CATENIN_SIGNALING,Head and Neck Squamous Cell Carcinoma,0.006144266957558953
HALLMARK_WNT_BETA_CATENIN_SIGNALING,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.0038358846984126423
HALLMARK_XENOBIOTIC_METABOLISM,Kidney Renal Papillary Cell Carcinoma,0.012586785711606102
HALLMARK_XENOBIOTIC_METABOLISM,Thyroid Carcinoma,0.001518828455697406
HALLMARK_XENOBIOTIC_METABOLISM,Liver Hepatocellular Carcinoma,0.020271637931436614
HALLMARK_XENOBIOTIC_METABOLISM,Breast Invasive Carcinoma,0.006917675494992342
HALLMARK_XENOBIOTIC_METABOLISM,Prostate Adenocarcinoma,0.002184648033933806
HALLMARK_XENOBIOTIC_METABOLISM,Bladder Urothelial Carcinoma,0.03860852464593412
HALLMARK_XENOBIOTIC_METABOLISM,Stomach Adenocarcinoma,0.018745279423485285
HALLMARK_XENOBIOTIC_METABOLISM,Lung Squamous Cell Carcinoma,0.03102807448125868
HALLMARK_XENOBIOTIC_METABOLISM,Ovarian Serous Cystadenocarcinoma,0.018148907216627208
HALLMARK_XENOBIOTIC_METABOLISM,Brain Lower Grade Glioma,0.007610576753950082
HALLMARK_XENOBIOTIC_METABOLISM,Skin Cutaneous Melanoma,0.028248937490842608
HALLMARK_XENOBIOTIC_METABOLISM,Lung Adenocarcinoma,0.030696540655405058
HALLMARK_XENOBIOTIC_METABOLISM,Kidney Renal Clear Cell Carcinoma,0.010879870647421241
HALLMARK_XENOBIOTIC_METABOLISM,Colon Adenocarcinoma,0.0245409091230619
HALLMARK_XENOBIOTIC_METABOLISM,Uterine Corpus Endometrial Carcinoma,0.009474066280621751
HALLMARK_XENOBIOTIC_METABOLISM,Head and Neck Squamous Cell Carcinoma,0.024452642544271964
HALLMARK_XENOBIOTIC_METABOLISM,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,0.02304661085659808
